Business description: PCAS

- synthesized pharmaceutical products (63.5%);
- fine chemicals (36.5%): technical fluids and additives for the lubricant industry, chemical additive synthesis. The group also offers photochemical and new technology products (photosensitive materials, photo-initiators, and polymers for photography, reprography, and micro-electronics).
At the end of 2022, the group had 7 production sites located in France (5), Canada and Finland.
France accounts for 76% of net sales.
Number of employees: 1,178
Sales by Activity: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
Pharmaceutical Synthesis | 128M | 135M | 120M | 144M |
Fine Speciality Chemicals | 73.25M | 58.92M | 67.41M | 82.72M |
Geographical breakdown of sales: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
France | 163M | 155M | 143M | 172M |
Other Areas | 38.01M | 38.92M | 44.36M | 54.3M |
Executive Committee: PCAS
| Manager | Title | Age | Since |
|---|---|---|---|
Gildas Barreyre
CEO | Chief Executive Officer | 43 | 02/05/2025 |
Eric Moissenot
DFI | Director of Finance/CFO | - | - |
Gérard Guillamot
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/1999 |
Composition of the Board of Directors: PCAS
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 28/02/2014 | |
Janine Cossy
BRD | Director/Board Member | - | - |
Company details: PCAS
PCAS SA
21, Chemin de la Sauvegarde
69134, Écully
+33 1 69 09 77 85

Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.48% | -6.72% | +44.19% | +156.43% | 1,054B | ||
| -1.52% | -5.01% | +61.87% | +58.79% | 621B | ||
| -1.30% | -3.88% | +27.81% | +79.97% | 438B | ||
| -1.12% | -3.68% | +26.89% | +20.58% | 325B | ||
| -1.73% | -3.45% | +26.95% | +44.09% | 281B | ||
| -1.95% | -13.92% | +15.96% | +19.76% | 262B | ||
| -1.45% | -2.37% | -27.87% | -39.87% | 219B | ||
| -1.44% | -3.49% | +19.60% | +56.20% | 195B | ||
| -1.04% | -4.63% | +16.01% | +68.47% | 163B | ||
| Average | -1.24% | -1.70% | +23.49% | +51.60% | 395.13B | |
| Weighted average by Cap. | -0.90% | -1.69% | +33.17% | +77.04% |

















